Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/21/2003WO2003069341A2 Method of diagnosis of inflammatory diseases using calgranulin c
08/21/2003WO2003069340A1 Diluent, methods of manufacture and use
08/21/2003WO2003069339A1 Method for generating recombinant human platelets for identifying therapeutic target proteins
08/21/2003WO2003069338A2 Analysis of vital substances
08/21/2003WO2003069337A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
08/21/2003WO2003069336A2 Cd16b as a marker for the diagnosis of endometriosis
08/21/2003WO2003069335A1 Device and method for determining parameters
08/21/2003WO2003069334A1 Use of a capacitive probe to determine the biomass of small bacteria
08/21/2003WO2003069332A2 Detection and/or monitoring of synuclein-related diseases
08/21/2003WO2003069331A1 Method for casein determination in milk
08/21/2003WO2003069330A1 System and method for identifying proteins involved in force-initiated signal transduction
08/21/2003WO2003069328A1 Method of analyzing aminofunctional compound and analytical reagent
08/21/2003WO2003069326A1 Measuring device and removal device for stored object
08/21/2003WO2003069312A2 Molecular sensors by competitive activation
08/21/2003WO2003069310A2 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia
08/21/2003WO2003069309A2 Immunocapture and functional assay for mitochondrial complex i
08/21/2003WO2003069308A2 Method of determining an analyte concentration in a sample from an absorption spectrum
08/21/2003WO2003069307A2 Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
08/21/2003WO2003069305A2 Fluorescent phospholipase assay, phospholipase a2 inhibitor and stimulator, and the use thereof
08/21/2003WO2003069304A2 Method and apparatus for assay of electrochemical properties
08/21/2003WO2003069301A2 Conductimetric biosensor device, method and system
08/21/2003WO2003068990A1 METHODS FOR THE PREPARATION OF CHEMICALLY MISAMINOACYLATED tRNA VIA PROTECTIVE GROUPS
08/21/2003WO2003068987A2 Discriminative analysis of clone signature
08/21/2003WO2003068983A1 Use of the axl receptor for diagnosis and treatment of renal disease
08/21/2003WO2003068982A1 Bio-cell chip
08/21/2003WO2003068981A2 Method for reducing background contamination after marking reactions
08/21/2003WO2003068979A2 System and methods for discriminating an agent
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068963A1 Deoxyribozymes
08/21/2003WO2003068962A1 Separating method and an apparatus performing such a method
08/21/2003WO2003068958A1 Method of analyzing nucleic acid specifying gene showing change in expression dose due to schizophrenia
08/21/2003WO2003068957A1 METHOD OF SCREENING INK4 FAMILY GENE EXPRESSION CONTROLLER AND p19 GENE PROMOTER
08/21/2003WO2003068947A1 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
08/21/2003WO2003068945A2 Detection of molecular interaction by reactivation of an auto-inhibited responder (rair)
08/21/2003WO2003068944A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068940A2 Complexes and methods of using same
08/21/2003WO2003068935A2 Methods of therapy and diagnosis
08/21/2003WO2003068932A2 Method for crystallizing human gsk3 and novel crystal structure thereof
08/21/2003WO2003068931A2 Purification of the leading front migratory cells
08/21/2003WO2003068928A2 Gene function inferring using gene expression data
08/21/2003WO2003068925A2 Production of a protein delivery system for in vivo therapeutic treatment
08/21/2003WO2003068921A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2003068919A2 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003WO2003068916A2 Methods and apparatus for whole cell panning
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068914A2 Solution structure of rip dd and uses therof
08/21/2003WO2003068913A2 Synthesis of 2h- and 13c- substituted dithianes
08/21/2003WO2003068908A2 Cardiotoxin molecular toxicology modeling
08/21/2003WO2003068907A2 Method for the generation of proteins with new enzymatic function
08/21/2003WO2003068906A1 Systems and methods for rapidly changing the solution environment around sensors
08/21/2003WO2003068820A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068788A1 Method of isolating nucleic acids from stool samples
08/21/2003WO2003068712A2 Novel method for production of dna biochips and applications thereof
08/21/2003WO2003068709A1 Optimized device for the regulation and measurement of gas content in composting platforms or platforms for the treatment of waste with measuring probes
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068170A2 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003WO2003068167A2 Novel treatment for pathologies associated with oxidative damage
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068150A2 Methods of treating and diagnosing arthritis
08/21/2003WO2003068147A2 Treatments for neurotoxicity in alzheimer’s disease
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068071A1 Integrally storable adaptor
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003058250A3 Compositional protein analysis
08/21/2003WO2003056296A8 Improved methods for determining binding affinities
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003055904A3 Peptidyl-trna hydrolase from pseudomonas aeruginosa
08/21/2003WO2003054014A3 Apolipoprotein biopolymer markers predictive of alzheimers disease
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003047037A3 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors
08/21/2003WO2003045227A3 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003040394A3 Production of recombinant proteins in vivo and use for generating antibodies
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003032558A3 METHOD AND A SYSTEM FOR AUTOMATING THE EXECUTION OF AMoRe OVER A HETEROGENOUS NETWORK OF COMPUTERS
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003029425A3 Whole cell engineering using real-time metabolic flux analysis
08/21/2003WO2003028631A3 Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
08/21/2003WO2003025554A3 Method quantitative video-microscopy and associated system and computer software program product
08/21/2003WO2003024308A3 Methods of assaying connective tissue growth factor
08/21/2003WO2003021256A8 Method for identifying polymorphic markers in a population
08/21/2003WO2003021245A3 Sensor
08/21/2003WO2003018760A3 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003016504A3 Polymorphisms associated with ion-channel disease
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003015871A3 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption
08/21/2003WO2003014699A8 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism
08/21/2003WO2003008937A3 Gas-focusing flow cytometer cell and flow cytometer detection system with waveguide optics
08/21/2003WO2003008643A3 Methods and polynukleotides for assaying the activity of a dna modifying enzyme
08/21/2003WO2003008539A3 Non-alloying core shell nanoparticles
08/21/2003WO2003004006A8 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
08/21/2003WO2003002609A3 Dual-specific ligand and its use
1 ... 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 ... 3937